Cetera Investment Advisers
MEDP icon

Cetera Investment Advisers’s Medpace MEDP Stock Holding History

Cetera Investment Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18M Sell
9,780
-7,101
-42% -$3.28M ﹤0.01% 1595
2026
Q1 		$8.11M Sell
16,881
-3,189
-16% -$1.63M 0.01% 1190
2025
Q4 		$11.3M Buy
20,070
+4,649
+30% +$2.64M 0.01% 957
2025
Q3 		$7.93M Buy
15,421
+3,084
+25% +$1.35M 0.01% 1130
2025
Q2 		$3.87M Buy
12,337
+323
+3% +$97K 0.01% 1354
2025
Q1 		$3.66M Sell
12,014
-18
-0.1% -$6.05K 0.01% 1315
2024
Q4 		$4M Buy
12,032
+953
+9% +$323K 0.01% 1170
2024
Q3 		$3.7M Sell
11,079
-678
-6% -$258K 0.01% 1185
2024
Q2 		$4.84M Buy
11,757
+263
+2% +$104K 0.01% 1021
2024
Q1 		$4.65M Buy
11,494
+8,063
+235% +$2.83M 0.01% 1024
2023
Q4 		$1.05M Buy
3,431
+777
+29% +$210K 0.01% 1083
2023
Q3 		$643K Buy
+2,654
New +$679K 0.01% 1292

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cetera Investment Advisers's MEDP Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Medpace (MEDP) stake by 42% in Q2 2026, selling an estimated $3.28M and leaving 9,780 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Cetera Investment Advisers first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $11.3M in Q4 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Cetera Investment Advisers held 9,780 shares of Medpace worth $5.18M as of Q2 2026.
  • Cetera Investment Advisers sold 7,101 Medpace shares in Q2 2026, an estimated $3.28M.
  • Medpace made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1595 holding.
  • Cetera Investment Advisers first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
  • Cetera Investment Advisers's Medpace position peaked at $11.3M in Q4 2025.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.